Hepatology (Baltimore, Md.)

Keyphrases

Publications

volume 80, number 2, 2024

Hong Gao, Karina C E Rocha, Zhongmou Jin, Deepak Kumar, Dinghong Zhang, Ke Wang, Manasi Das, Andrea Farrell, Tyler Truong, Yasemin Tekin, Hyun Suh Jung, Julia Kempf, Nicholas J G Webster, Wei Ying
Restoring SRSF3 in Kupffer cells attenuates obesity-related insulin resistance. Hepatology (Baltimore, Md.) 80 (2) (2024)
Zhenwei Peng, Guangyan Wei, Pinzhu Huang, Heansika Matta, Wen Gao, Ping An, Shuangshuang Zhao, Yi Lin, Li Tan, Kahini Vaid, Disha Skelton-Badlani, Imad Nasser, Grant Budas, David Lopez, Li Li, David Breckenridge, Rob Myers, John McHutchison, Ming Kuang, Yury V Popov
ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer. Hepatology (Baltimore, Md.) 80 (2) (2024)

volume 80, number 3, 2024

Zheng Li, Yi Zhang, Ying Li, Xi Chen, Jie Hu, Jiayun Yu, Yuzhu Hu, Shihong Nie, Nanjing Li, Qinglian Wen, Bingwen Zou
Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC? Hepatology (Baltimore, Md.) 80 (3) (2024)
Daniel Q Huang, Mindie H Nguyen
Reply: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC? Hepatology (Baltimore, Md.) 80 (3) (2024)
Sandy Feng, Garrett R Roll, Foad J Rouhani, Alberto Sanchez Fueyo
The future of liver transplantation. Hepatology (Baltimore, Md.) 80 (3) (2024)
Sung Won Chung, Hye-Sung Moon, Hyunjae Shin, Hyein Han, Sehoon Park, Heejin Cho, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Sung-Ho Won, Yun Bin Lee, Eun-Ju Cho, Su Jong Yu, Dong-Ki Kim, Jung Hwan Yoon, Jeong-Hoon Lee, Yun Joon Kim
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study. Hepatology (Baltimore, Md.) 80 (3) (2024)
James K Carter, Ming-Chao Tsai, Nicholas J Venturini, Jiangting Hu, John J Lemasters, Miguel Torres Martin, Daniela Sia, Shuang Wang, Youngmin A Lee, Scott L Friedman
Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contraction. Hepatology (Baltimore, Md.) 80 (3) (2024)
Cody Z Watling, Aika Wojt, Andrea A Florio, Gisela Butera, Demetrius Albanes, Stephanie J Weinstein, Wen-Yi Huang, Dominick Parisi, Barry I Graubard, Barry I Graubard, Jessica L Petrick, Katherine A McGlynn
Fiber and whole grain intakes in relation to liver cancer risk: An analysis in 2 prospective cohorts and systematic review and meta-analysis of prospective studies. Hepatology (Baltimore, Md.) 80 (3) (2024)
James K Carter, Ming-Chao Tsai, Nicholas J Venturini, Jiangting Hu, John J Lemasters, Miguel Torres Martin, Daniela Sia, Shuang Wang, Youngmin A Lee, Scott L Friedman
Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contraction. Hepatology (Baltimore, Md.) 80 (3) (2024)
Stephanie Y Tsai, Jacqueline G O'Leary
Let's Pump You Up! Hepatology (Baltimore, Md.) 80 (3) (2024)
Ryma Terbah, Adam G Testro, Rudolf Hoermann, Avik Majumdar, Brooke Chapman, Paul J Gow, Marie Sinclair
Continuous home terlipressin infusion increases handgrip strength and reduces ascites-A prospective randomized crossover study. Hepatology (Baltimore, Md.) 80 (3) (2024)
Cody Z Watling, Aika Wojt, Andrea A Florio, Gisela Butera, Demetrius Albanes, Stephanie J Weinstein, Wen-Yi Huang, Dominick Parisi, Barry I Graubard, Barry I Graubard, Jessica L Petrick, Katherine A McGlynn
Fiber and whole grain intakes in relation to liver cancer risk: An analysis in 2 prospective cohorts and systematic review and meta-analysis of prospective studies. Hepatology (Baltimore, Md.) 80 (3) (2024)
Yihong Chen, Xiangying Deng, Yin Li, Ying Han, Yinghui Peng, Wantao Wu, Xinwen Wang, Jiayao Ma, Erya Hu, Xin Zhou, Edward Shen, Shan Zeng, Changjing Cai, Yiming Qin, Hong Shen
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC. Hepatology (Baltimore, Md.) 80 (3) (2024)
Yuanguo Wang, Xianghu Wang, Bing Bai, Aurpita Shaha, Xipu He, Yingzi He, Zhenqing Ye, Vijay H Shah, Ningling Kang
Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology (Baltimore, Md.) 80 (3) (2024)
Mayur Brahmania, Alexander Kuo, Elliot B Tapper, Michael L Volk, Jennifer Mary Vittorio, Marwan S Ghabril, Timothy R Morgan, Fasiha Kanwal, Neehar D Parikh, Paul Martin, Shivang Mehta, Gerald Scott Winder, Gene Y Im, David S Goldberg, Jennifer C Lai, Andrés Duarte-Rojo, Angelo H Paredes, Arpan A Patel, Amandeep Sahota, Lisa M McElroy, Charlie Thomas, Anji E Wall, Maricar F Malinis, Saima Aslam, Douglas A Simonetto, Nneka N Ufere, Sudha Ramakrishnan, Mary Margaret Flynn, Yasmin Ibrahim, Sumeet K Asrani, Marina Serper
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.) 80 (3) (2024)
Aiva Lundberg Båve, Erik von Seth, Michael Ingre, Caroline Nordenvall, Annika Bergquist
Autoimmune diseases in primary sclerosing cholangitis and their first-degree relatives. Hepatology (Baltimore, Md.) 80 (3) (2024)
Bikrant Bihari Lal, Seema Alam, Anupam Sibal, Karunesh Kumar, Somashekara Hosaagrahara Ramakrishna, Vaibhav Shah, Nirmala Dheivamani, Ashish Bavdekar, Aabha Nagral, Nishant Wadhwa, Arjun Maria, Aashay Shah, Ira Shah, Zahabiya Nalwalla, Pandey Snehavardhan, K P Srikanth, Subhash Gupta, Viswanathan M Sivaramakrishnan, Yogesh Waikar, Arya Suchismita, A Ashritha, Vikrant Sood, Rajeev Khanna, null null
Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency-related cholestasis. Hepatology (Baltimore, Md.) 80 (3) (2024)
Yuanguo Wang, Xianghu Wang, Bing Bai, Aurpita Shaha, Xipu He, Yingzi He, Zhenqing Ye, Vijay H Shah, Ningling Kang
Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology (Baltimore, Md.) 80 (3) (2024)
Meng Zhu, Mengqi Qu, Shengxia Lv, Jinfang Zhang, Yongsheng Zhang, Fuzhen Pan
Letter to the Editor: Enhancing the rigor and impact of cholangiocarcinoma research: Addressing key concerns in the PTPN9-FGFR2 interaction study. Hepatology (Baltimore, Md.) 80 (3) (2024)
Tuo Deng, Gang Chen
Single-cell-based molecular classification in systematic treatment of hepatocellular carcinoma: From in silico to bedside. Hepatology (Baltimore, Md.) 80 (3) (2024)
Lucia M Calthorpe, Sy Han Chiou, Jessica Rubin, Chiung-Yu Huang, Sandy Feng, Jennifer C Lai
A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations. Hepatology (Baltimore, Md.) 80 (3) (2024)
Bikrant Bihari Lal, Seema Alam, Anupam Sibal, Karunesh Kumar, Somashekara Hosaagrahara Ramakrishna, Vaibhav Shah, Nirmala Dheivamani, Ashish Bavdekar, Aabha Nagral, Nishant Wadhwa, Arjun Maria, Aashay Shah, Ira Shah, Zahabiya Nalwalla, Pandey Snehavardhan, K P Srikanth, Subhash Gupta, Viswanathan M Sivaramakrishnan, Yogesh Waikar, Arya Suchismita, A Ashritha, Vikrant Sood, Rajeev Khanna, null null
Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency-related cholestasis. Hepatology (Baltimore, Md.) 80 (3) (2024)
Christopher Dietz, Elisabetta Degasperi, Mathias Jachs, Benjamin Maasoumy, Florian P Reiter, Andreas Geier, Julia M Grottenthaler, Christoph P Berg, Kathrin Sprinzl, Stefan Zeuzem, Juliana Gödiker, Bernhard Schlevogt, Toni Herta, Johannes Wiegand, Roberta Soffredini, Heiner Wedemeyer, Katja Deterding, Thomas Reiberger, Pietro Lampertico
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series. Hepatology (Baltimore, Md.) 80 (3) (2024)
Jordi Gratacós-Ginès, Pilar Ruz-Zafra, Miriam Celada-Sendino, Aina Martí-Carretero, Clàudia Pujol, Rosa Martín-Mateos, Víctor Echavarría, Luis E Frisancho, Sonia García, Mónica Barreales, Javier Tejedor-Tejada, Sergio Vázquez-Rodríguez, Nuria Cañete, Carlos Fernández-Carrillo, María Valenzuela, David Martí-Aguado, Diana Horta, Marta Quiñones, Vanesa Bernal-Monterde, Silvia Acosta, Tomás Artaza, José Pinazo, Carmen Villar-Lucas, Ana Clemente-Sánchez, Ester Badia-Aranda, Álvaro Giráldez-Gallego, Manuel Rodríguez, Pau Sancho-Bru, Joaquín Cabezas, Meritxell Ventura-Cots, Conrado Fernández-Rodríguez, Victoria Aguilera, Santiago Tomé, Ramon Bataller, Juan Caballería, Elisa Pose, null null
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality. Hepatology (Baltimore, Md.) 80 (3) (2024)
Mayur Brahmania, Alexander Kuo, Elliot B Tapper, Michael L Volk, Jennifer Mary Vittorio, Marwan S Ghabril, Timothy R Morgan, Fasiha Kanwal, Neehar D Parikh, Paul Martin, Shivang Mehta, Gerald Scott Winder, Gene Y Im, David S Goldberg, Jennifer C Lai, Andrés Duarte-Rojo, Angelo H Paredes, Arpan A Patel, Amandeep Sahota, Lisa M McElroy, Charlie Thomas, Anji E Wall, Maricar F Malinis, Saima Aslam, Douglas A Simonetto, Nneka N Ufere, Sudha Ramakrishnan, Mary Margaret Flynn, Yasmin Ibrahim, Sumeet K Asrani, Marina Serper
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.) 80 (3) (2024)
Daniel Q Huang, Mindie H Nguyen
Reply: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC? Hepatology (Baltimore, Md.) 80 (3) (2024)
Lucia M Calthorpe, Sy Han Chiou, Jessica Rubin, Chiung-Yu Huang, Sandy Feng, Jennifer C Lai
A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations. Hepatology (Baltimore, Md.) 80 (3) (2024)
Sandy Feng, Garrett R Roll, Foad J Rouhani, Alberto Sanchez Fueyo
The future of liver transplantation. Hepatology (Baltimore, Md.) 80 (3) (2024)
Meng Zhu, Mengqi Qu, Shengxia Lv, Jinfang Zhang, Yongsheng Zhang, Fuzhen Pan
Letter to the Editor: Enhancing the rigor and impact of cholangiocarcinoma research: Addressing key concerns in the PTPN9-FGFR2 interaction study. Hepatology (Baltimore, Md.) 80 (3) (2024)
Tuo Deng, Gang Chen
Single-cell-based molecular classification in systematic treatment of hepatocellular carcinoma: From in silico to bedside. Hepatology (Baltimore, Md.) 80 (3) (2024)
Christopher Dietz, Elisabetta Degasperi, Mathias Jachs, Benjamin Maasoumy, Florian P Reiter, Andreas Geier, Julia M Grottenthaler, Christoph P Berg, Kathrin Sprinzl, Stefan Zeuzem, Juliana Gödiker, Bernhard Schlevogt, Toni Herta, Johannes Wiegand, Roberta Soffredini, Heiner Wedemeyer, Katja Deterding, Thomas Reiberger, Pietro Lampertico
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series. Hepatology (Baltimore, Md.) 80 (3) (2024)
Bo Sun, Kelly A S da Costa, Aljawharah Alrubayyi, Jonida Kokici, Natasha Fisher-Pearson, Noshin Hussain, Stefano D'Anna, Lorenzo Piermatteo, Romina Salpini, Valentina Svicher, Stephanie Kucykowicz, Indrajit Ghosh, Fiona M Burns, Sabine Kinloch, Pedro Simoes, Sanjay Bhagani, Patrick T F Kennedy, Mala K Maini, Rachael J M Bashford-Rogers, Upkar S Gill, Dimitra Peppa
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses. Hepatology (Baltimore, Md.) 80 (3) (2024)
Ryma Terbah, Adam G Testro, Rudolf Hoermann, Avik Majumdar, Brooke Chapman, Paul J Gow, Marie Sinclair
Continuous home terlipressin infusion increases handgrip strength and reduces ascites-A prospective randomized crossover study. Hepatology (Baltimore, Md.) 80 (3) (2024)
Jordi Gratacós-Ginès, Pilar Ruz-Zafra, Miriam Celada-Sendino, Aina Martí-Carretero, Clàudia Pujol, Rosa Martín-Mateos, Víctor Echavarría, Luis E Frisancho, Sonia García, Mónica Barreales, Javier Tejedor-Tejada, Sergio Vázquez-Rodríguez, Nuria Cañete, Carlos Fernández-Carrillo, María Valenzuela, David Martí-Aguado, Diana Horta, Marta Quiñones, Vanesa Bernal-Monterde, Silvia Acosta, Tomás Artaza, José Pinazo, Carmen Villar-Lucas, Ana Clemente-Sánchez, Ester Badia-Aranda, Álvaro Giráldez-Gallego, Manuel Rodríguez, Pau Sancho-Bru, Joaquín Cabezas, Meritxell Ventura-Cots, Conrado Fernández-Rodríguez, Victoria Aguilera, Santiago Tomé, Ramon Bataller, Juan Caballería, Elisa Pose, null null
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality. Hepatology (Baltimore, Md.) 80 (3) (2024)
Lucia M Calthorpe, Sy Han Chiou, Jessica Rubin, Chiung-Yu Huang, Sandy Feng, Jennifer C Lai
A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations. Hepatology (Baltimore, Md.) 80 (3) (2024)
Mohamed Alboraie, Yasser Mahrous Fouad, Mohammed Eslam
Letter to the Editor: MAFLD versus MASLD-Which is more appropriate from a global perspective? Hepatology (Baltimore, Md.) 80 (3) (2024)
Xingmei Liao, Rong Fan
Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients. Hepatology (Baltimore, Md.) 80 (3) (2024)
Robert M Wilechansky
Fellows' Corner. Hepatology (Baltimore, Md.) 80 (3) (2024)
Rosanna Villani, Gaetano Serviddio
Letter to the Editor: Multifactorial steatotic liver disease: A new entity to be included in new international classification of liver steatosis. Hepatology (Baltimore, Md.) 80 (3) (2024)
Yuanguo Wang, Xianghu Wang, Bing Bai, Aurpita Shaha, Xipu He, Yingzi He, Zhenqing Ye, Vijay H Shah, Ningling Kang
Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology (Baltimore, Md.) 80 (3) (2024)
Bo Sun, Kelly A S da Costa, Aljawharah Alrubayyi, Jonida Kokici, Natasha Fisher-Pearson, Noshin Hussain, Stefano D'Anna, Lorenzo Piermatteo, Romina Salpini, Valentina Svicher, Stephanie Kucykowicz, Indrajit Ghosh, Fiona M Burns, Sabine Kinloch, Pedro Simoes, Sanjay Bhagani, Patrick T F Kennedy, Mala K Maini, Rachael J M Bashford-Rogers, Upkar S Gill, Dimitra Peppa
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses. Hepatology (Baltimore, Md.) 80 (3) (2024)
Mohamed Alboraie, Yasser Mahrous Fouad, Mohammed Eslam
Letter to the Editor: MAFLD versus MASLD-Which is more appropriate from a global perspective? Hepatology (Baltimore, Md.) 80 (3) (2024)
Stephanie Y Tsai, Jacqueline G O'Leary
Let's Pump You Up! Hepatology (Baltimore, Md.) 80 (3) (2024)
Yuanguo Wang, Xianghu Wang, Bing Bai, Aurpita Shaha, Xipu He, Yingzi He, Zhenqing Ye, Vijay H Shah, Ningling Kang
Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology (Baltimore, Md.) 80 (3) (2024)
Aiva Lundberg Båve, Erik von Seth, Michael Ingre, Caroline Nordenvall, Annika Bergquist
Autoimmune diseases in primary sclerosing cholangitis and their first-degree relatives. Hepatology (Baltimore, Md.) 80 (3) (2024)
Sung Won Chung, Hye-Sung Moon, Hyunjae Shin, Hyein Han, Sehoon Park, Heejin Cho, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Sung-Ho Won, Yun Bin Lee, Eun-Ju Cho, Su Jong Yu, Dong-Ki Kim, Jung Hwan Yoon, Jeong-Hoon Lee, Yun Joon Kim
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study. Hepatology (Baltimore, Md.) 80 (3) (2024)
Yihong Chen, Xiangying Deng, Yin Li, Ying Han, Yinghui Peng, Wantao Wu, Xinwen Wang, Jiayao Ma, Erya Hu, Xin Zhou, Edward Shen, Shan Zeng, Changjing Cai, Yiming Qin, Hong Shen
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC. Hepatology (Baltimore, Md.) 80 (3) (2024)
Zheng Li, Yi Zhang, Ying Li, Xi Chen, Jie Hu, Jiayun Yu, Yuzhu Hu, Shihong Nie, Nanjing Li, Qinglian Wen, Bingwen Zou
Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC? Hepatology (Baltimore, Md.) 80 (3) (2024)
Xingmei Liao, Rong Fan
Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients. Hepatology (Baltimore, Md.) 80 (3) (2024)
Rosanna Villani, Gaetano Serviddio
Letter to the Editor: Multifactorial steatotic liver disease: A new entity to be included in new international classification of liver steatosis. Hepatology (Baltimore, Md.) 80 (3) (2024)